SCHEMBL18200564

SCHEMBL18200564

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(-c5nc6ccccc6c6c5ccc5ccccc56)c4)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.43
HPGD P15428 6/20 0.42
ALDH1A1 P00352 5/20 0.42
MAPT P10636 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
LMNA P02545 5/20 0.41
DHODH Q02127 1/20 0.41
NTSR1 P30989 1/20 0.40
ACHE P22303 1/20 0.39
ATM Q13315 1/20 0.39
GLA P06280 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 1/20 0.39
NPY1R P25929 1/20 0.39
HTT P42858 1/20 0.39
NPY2R P49146 1/20 0.39
RAB9A P51151 1/20 0.39
NQO2 P16083 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200562 1.00 PTGES (0.43) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18201133 0.99 PTGES (0.42) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18200350 0.99 PTGES (0.42) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18200349 0.99 PTGES (0.42) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18201130 0.97 ALDH1A1 (0.43) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18200587 0.96 ALDH1A1 (0.43) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18201244 0.96 MAPT (0.44) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18200397 0.96 ALDH1A1 (0.43) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18201247 0.96 MAPT (0.44) PTGESHPGDALDH1A1MAPTKDM4E
SCHEMBL18201131 0.96 MAPT (0.42) PTGESHPGDALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 PTGES 558/4885HPGD 421/4885ALDH1A1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.